FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006985444> ?p ?o ?g. }

• W3006985444 endingPage "1243" @default.
• W3006985444 startingPage "1235" @default.
• W3006985444 abstract "To compare the effectiveness and safety of transjugular intrahepatic portosystemic shunt (TIPS) with endoscopic therapy plus non-selective β-blockers (NSBBs) for secondary prevention of gasroesophageal variceal bleeding (GEVB) in cirrhotic patients with high-risk factors of treatment failure.A total of 122 cirrhotic patients with history of gasroesophageal variceal bleeding and high factors including hepatic vein pressure gradient (HVPG) ≥ 20 mmHg, portal vein thrombosis (PVT), gastrorenal shunt (GRS), or extraluminal para-gastric veins (ep-GVs) detected by endoscopic ultrasound, were analyzed retrospectively. Seventy-seven patients underwent TIPS with PTFE-covered stent (group A) and 102 patients received endoscopic therapy combined with nonselective β-blockers (NSBBs) (group B). According to above high-risk factors, both groups were stratified into four paired subgroups (A1-A4 and B1-B4). Two-year rebleeding rate, overt hepatic encephalopathy, overall survival, and procedure-related adverse events were compared between the two groups and paired subgroups.The 2-year cumulative probability of free of variceal rebleeding was higher in group A than group B (93 vs. 62%, P < 0.001). Similarly, the 2-year cumulative probability of free of variceal rebleeding was also higher in the subgroups A1-A4 than the subgroups B1-B4 (91 vs. 67%, P = 0.022, 90 vs. 67%, P = 0.021, 94 vs. 59%, P = 0.029, and 90 vs. 58%, P = 0.016, respectively). There was no significant difference between the two groups and corresponding subgroups in overt hepatic encephalopathy and survival.Compared to secondary prophylaxis with endoscopic therapy plus NSBBs, polytetrafluoroethylene-covered TIPS could significantly reduce the variceal rebleeding rate in cirrhotic patients with HVPG ≥ 20 mmHg, PVT, GRS, or ep-GVs, without increasing the incidence of hepatic encephalopathy." @default.
• W3006985444 created "2020-03-06" @default.
• W3006985444 creator A5007154734 @default.
• W3006985444 creator A5017619157 @default.
• W3006985444 creator A5023521085 @default.
• W3006985444 creator A5029348144 @default.
• W3006985444 creator A5055657355 @default.
• W3006985444 creator A5057360522 @default.
• W3006985444 creator A5064203621 @default.
• W3006985444 creator A5067039459 @default.
• W3006985444 creator A5078949281 @default.
• W3006985444 creator A5082301281 @default.
• W3006985444 date "2020-03-05" @default.
• W3006985444 modified "2023-09-27" @default.
• W3006985444 title "PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks" @default.
• W3006985444 cites W1507700591 @default.
• W3006985444 cites W1525534239 @default.
• W3006985444 cites W1978304182 @default.
• W3006985444 cites W1979518849 @default.
• W3006985444 cites W1997143480 @default.
• W3006985444 cites W2004320348 @default.
• W3006985444 cites W2021152648 @default.
• W3006985444 cites W2026305361 @default.
• W3006985444 cites W2033891364 @default.
• W3006985444 cites W2038601870 @default.
• W3006985444 cites W2048876151 @default.
• W3006985444 cites W2057657489 @default.
• W3006985444 cites W2095764663 @default.
• W3006985444 cites W2103280958 @default.
• W3006985444 cites W2103588891 @default.
• W3006985444 cites W2105932465 @default.
• W3006985444 cites W2107976984 @default.
• W3006985444 cites W2120116531 @default.
• W3006985444 cites W2134599653 @default.
• W3006985444 cites W2146391053 @default.
• W3006985444 cites W2148791665 @default.
• W3006985444 cites W2171716651 @default.
• W3006985444 cites W2259448166 @default.
• W3006985444 cites W2409100 @default.
• W3006985444 cites W2470279690 @default.
• W3006985444 cites W2546046192 @default.
• W3006985444 cites W2562989657 @default.
• W3006985444 cites W2617370121 @default.
• W3006985444 cites W2758879202 @default.
• W3006985444 cites W2802212832 @default.
• W3006985444 cites W2802906787 @default.
• W3006985444 cites W2908836303 @default.
• W3006985444 cites W571628560 @default.
• W3006985444 doi "https://doi.org/10.1097/meg.0000000000001686" @default.
• W3006985444 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7423526" @default.
• W3006985444 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32744824" @default.
• W3006985444 hasPublicationYear "2020" @default.
• W3006985444 type Work @default.
• W3006985444 sameAs 3006985444 @default.
• W3006985444 citedByCount "5" @default.
• W3006985444 countsByYear W30069854442021 @default.
• W3006985444 countsByYear W30069854442022 @default.
• W3006985444 countsByYear W30069854442023 @default.
• W3006985444 crossrefType "journal-article" @default.
• W3006985444 hasAuthorship W3006985444A5007154734 @default.
• W3006985444 hasAuthorship W3006985444A5017619157 @default.
• W3006985444 hasAuthorship W3006985444A5023521085 @default.
• W3006985444 hasAuthorship W3006985444A5029348144 @default.
• W3006985444 hasAuthorship W3006985444A5055657355 @default.
• W3006985444 hasAuthorship W3006985444A5057360522 @default.
• W3006985444 hasAuthorship W3006985444A5064203621 @default.
• W3006985444 hasAuthorship W3006985444A5067039459 @default.
• W3006985444 hasAuthorship W3006985444A5078949281 @default.
• W3006985444 hasAuthorship W3006985444A5082301281 @default.
• W3006985444 hasBestOaLocation W30069854441 @default.
• W3006985444 hasConcept C126322002 @default.
• W3006985444 hasConcept C141071460 @default.
• W3006985444 hasConcept C197934379 @default.
• W3006985444 hasConcept C2777214474 @default.
• W3006985444 hasConcept C2778583881 @default.
• W3006985444 hasConcept C2778800853 @default.
• W3006985444 hasConcept C2778808290 @default.
• W3006985444 hasConcept C2779195621 @default.
• W3006985444 hasConcept C2780325230 @default.
• W3006985444 hasConcept C2781033279 @default.
• W3006985444 hasConcept C56900294 @default.
• W3006985444 hasConcept C71924100 @default.
• W3006985444 hasConcept C90924648 @default.
• W3006985444 hasConceptScore W3006985444C126322002 @default.
• W3006985444 hasConceptScore W3006985444C141071460 @default.
• W3006985444 hasConceptScore W3006985444C197934379 @default.
• W3006985444 hasConceptScore W3006985444C2777214474 @default.
• W3006985444 hasConceptScore W3006985444C2778583881 @default.
• W3006985444 hasConceptScore W3006985444C2778800853 @default.
• W3006985444 hasConceptScore W3006985444C2778808290 @default.
• W3006985444 hasConceptScore W3006985444C2779195621 @default.
• W3006985444 hasConceptScore W3006985444C2780325230 @default.
• W3006985444 hasConceptScore W3006985444C2781033279 @default.
• W3006985444 hasConceptScore W3006985444C56900294 @default.
• W3006985444 hasConceptScore W3006985444C71924100 @default.
• W3006985444 hasConceptScore W3006985444C90924648 @default.
• W3006985444 hasIssue "9" @default.
• W3006985444 hasLocation W30069854441 @default.

• next